FDA Inspection 1067221 — LifeServe Blood Center

LifeServe Blood Center — FEI 3011389677

The FDA completed an inspection of LifeServe Blood Center on September 27, 2018 in Sioux City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sioux City, IA (United States)